MNMD•benzinga•March 6, 2025 at 12:03 PM

Mind Medicine Q4 2024 GAAP EPS $(0.41) Misses $(0.30) Estimate, Cash And Cash Equivalents Of $273.7M As Of December 31, 2024, Expected To Fund Operations Into 2027 And Extend At Least 12 Months Beyond The First Phase 3 Topline Data Readout For MM120 Orall

No summary available.

Read the full article from the original source for complete details and context.

Article published on March 6, 2025 by benzinga